Skip to main content
. Author manuscript; available in PMC: 2023 Sep 29.
Published in final edited form as: Patient Educ Couns. 2013 Dec 25;95(2):271–280. doi: 10.1016/j.pec.2013.12.010

Table 6.

Weighted Means (Standard Errors and Standard Deviations) and Percentages of Dependent Variables by Numerical Format and Efficacy Level

Print Ad
Numerical Format Efficacy Level
Absolute Frequency Percent Absolute Frequency + Percent Relative Frequency Relative Frequency + Percent No Statistics Low High
N 268 261 266 249 282 136 680 646
Intention: Talk to doctor 2.09 (SE=0.09; SD=1.40) 1.98 (SE=0.07; SD=1.14) 1.96 (SE=0.08; SD=1.27) 1.93 (SE=0.07; SD=1.15) 1.89 (SE=0.07; SD=1.22) 1.93 (SE=0.11; SD=1.24) 1.95 (SE=0.04; SD=1.17) 1.99 (SE=0.05; SD=1.31)
Intention: Search for information 2.11 (SE=0.08; SD=1.25) 2.04 (SE=0.07; SD=1.18) 2.01 (SE=0.08; SD=1.25) 2.08 (SE=0.08; SD=1.23) 1.97 (SE=0.08; SD=1.30) 2.03 (SE=0.12; SD=1.43) 2.00 (SE=0.05; SD=1.21) 2.08 (SE=0.05; SD=1.28)
Intention: Take drug 2.45 (SE=0.08; SD=1.27) 2.45 (SE=0.08; SD=1.26) 2.33 (SE=0.08; SD=1.36) 2.43 (SE=0.08; SD=1.24) 2.37 (SE=0.08; SD=1.36) 2.30 (SE=0.11; SD=1.29) 2.36 (SE=0.05; SD=1.32) 2.41 (SE=0.05; SD=1.31)
Attitude toward the drug 3.04 (SE=0.06; SD=0.97) 3.11 (SE=0.06; SD=0.93) 3.07 (SE=0.07; SD=1.11) 3.13 (SE=0.06; SD=0.97) 3.01 (SE=0.06; SD=0.92) 2.89 (SE=0.10; SD=1.15) 3.04 (SE=0.04; SD=0.94) 3.10 (SE=0.04; SD=1.04)
Risk/benefit tradeoff 3.95 (SE=0.10; SD=1.63) 4.08 (SE=0.10; SD=1.61) 3.96 (SE=0.12; SD=2.02) 4.12 (SE=0.11; SD=1.78) 3.92 (SE=0.10; SD=1.65) 3.60 (SE=0.17; SD=1.96) 3.89 (SE=0.06; SD=1.64) 4.12 * (SE=0.07; SD=1.83)
Perceived benefit 4.25 (SE=0.12; SD=1.95) 4.21 (SE=0.13; SD=2.16) 4.37 (SE=0.12; SD=1.94) 4.50 (SE=0.14; SD=2.22) 4.31 (SE=0.12; SD=2.03) 4.03 (SE=0.22; SD=2.61) 4.24 (SE=0.08; SD=2.03) 4.42 (SE=0.08; SD=2.10)
Perceived risk 4.26 (SE=0.11; SD=1.82) 4.26 (SE=0.12; SD=1.93) 4.12 (SE=0.12; SD=2.0) 3.82 (SE=0.11; SD=1.79) 4.10 (SE=0.11; SD=1.78) 4.56 (SE=0.20; SD=2.27) 4.11 (SE=0.08; SD=1.90) 4.11 (SE=0.08; SD=1.90)
Aided risk recall 5.85 (SE=0.11; SD=1.73) 5.82 (SE=0.12; SD=1.93) 5.87 (SE=0.11; SD=1.85) 5.65 (SE=0.11; SD=1.79) 5.93 (SE=0.10; SD=1.71) 6.12 (SE=0.15; SD=1.74) 5.80 (SE=0.07; SD=1.80) 5.86 (SE=0.07; SD=1.85)
Unaided Risk recall (%) 83.42 78.00 83.46 83.61 81.40 83.18 80.41 83.67
Television Ad
N 238 244 238 243 258 124 621 600
Intention: Talk to doctor 1.89 (SE=0.07; SD=1.06) 1.69 (SE=0.07; SD=1.17) 1.90 (SE=0.07; SD=1.06) 1.93 (SE=0.07; SD=1.15) 1.72 (SE=0.07; SD=1.06) 1.79 (SE=0.10; SD=1.14) 1.77 (SE=0.04; SD=1.09) 1.88 (SE=0.05; SD=1.12)
Intention: Search for information 1.99 (SE=0.08; SD=1.16) 1.87 (SE=0.08; SD=1.20) 2.09 (SE=0.08; SD=1.21) 2.09 (SE=0.09; SD=1.34) 1.90 (SE=0.07; SD=1.16) 1.98 (SE=0.11; SD=1.23) 1.91 (SE=0.05; SD=1.22) 2.06 * (SE=0.05; SD=1.22)
Intention: Take drug 2.39 (SE=0.08; SD=1.17) 2.21 (SE=0.07; SD=1.11) 2.37 (SE=0.08; SD=1.16) 2.30 (SE=0.08; SD=1.22) 2.30 (SE=0.08; SD=1.27) 2.47 (SE=0.11; SD=1.21) 2.24 (SE=0.05; SD=1.19) 2.39 * (SE=0.05; SD=1.17)
Attitude toward the drug 3.08 (SE=0.06; SD=1.00) 2.94 (SE=0.06; SD=0.95) 3.02 (SE=0.06; SD=0.94) 3.02 (SE=0.07; SD=1.08) 2.93 (SE=0.06; SD=0.98) 2.88 (SE=0.07; SD=0.80) 2.91 (SE=0.04; SD=1.02) 3.09 * (SE=0.04; SD=0.95)
Risk/benefit tradeoff 3.83 (SE=0.11; SD=1.70) 3.75 (SE=0.10; SD=1.62) 3.90 (SE=0.10; SD=1.53) 3.92 (SE=0.11; SD=1.74) 3.76 (SE=0.11; SD=1.74) 3.83 (SE=0.14; SD=1.57) 3.69 (SE=0.07; SD=1.69) 3.98 * (SE=0.07; SD=1.64)
Perceived benefit 4.33 (SE=0.13; SD=1.94) 4.15 (SE=0.12; SD=1.89) 4.48 (SE=0.12; SD=1.87) 4.50 (SE=0.12; SD=1.93) 4.28 (SE=0.13; SD=2.09) 4.31 (SE=0.16; SD=1.75) 4.24 (SE=0.08; SD=2.01) 4.46 (SE=0.08; SD=1.86)
Perceived risk 4.20 (SE=0.11; SD=1.70) 4.36 (SE=0.10; SD=1.60) 4.08 (SE=0.10; SD=1.60) 4.18 (SE=0.11; SD=1.75) 4.30 (SE=0.10; SD=1.67) 4.07 (SE=0.16; SD=1.78) 4.32 (SE=0.07; SD=1.67) 4.13 (SE=0.07; SD=1.64)
Aided risk recall 6.40 (SE=0.12; SD=1.91) 6.50 (SE=0.12; SD=1.84) 6.38 (SE=0.11; SD=1.74) 6.49 (SE=0.10; SD=1.59) 6.47 (SE=0.12; SD=1.88) 6.36 (SE=0.14; SD=1.57) 6.44 (SE=0.07; SD=1.81) 6.46 (SE=0.07; SD=1.81)
Unaided risk recall (%) 85.85 80.88 85.01 87.25 90.98 87.83 86.69 85.32

Note. Intention measures were assessed on a scale from 1 = not at all likely to 4 = extremely likely. Attitude toward the drug was assessed on a scale from 1 = very bad to 5 = very good. Risk-benefit tradeoff was assessed on a scale from 1= more risks than benefits to 7 = more benefits than risks. Perceived benefit was assessed on a scale from 1 = not at all effective/well to 7 = very effective/well. Perceived risk was assessed on a scale from 1 = very safe/not at all risky to 7 = not at all safe/very risky. Aided risk recall is the sum of correct responses (0 to 8). Unaided risk recall is the percent who recalled one or more correct risks in an open-ended format. There were no significant differences among numerical format conditions on these measures.

*

Denotes significant difference compared with the low efficacy condition (P<.05).